World Journal of Pharmacology and Toxicology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • World J Pharmacol Toxico,

Revolutionizing Clinical Care: The Power of Pharmacogenomics

Rachel Wilson*
Department of Pharmacology, University of Florida, U.S.A
*Corresponding Author : Rachel Wilson, Department of Pharmacology, University of Florida, U.S.A, Email: rachelwilson@ufl.edu

Received Date: Mar 04, 2024 / Accepted Date: Mar 29, 2024 / Published Date: Mar 29, 2024

Abstract

Pharmacogenomics, the study of how genetic variations influence drug response, has emerged as a transformative tool in clinical care. This abstract explores the applications, benefits, and challenges of pharmacogenomics in healthcare. By analyzing genetic markers, clinicians can tailor treatment plans to individual patients, optimizing medication selection and dosing while minimizing adverse reactions. Pharmacogenomics has wide-ranging applications across medical specialties, from oncology to psychiatry, cardiology, and beyond. Its integration into clinical practice offers the promise of more precise and personalized treatment approaches, ultimately improving patient outcomes and ushering in a new era of precision medicine. Despite challenges such as cost and accessibility, pharmacogenomics represents a cornerstone of modern healthcare, shaping the future of personalized medicine and revolutionizing patient care.

Citation: Rachel W (2024) Revolutionizing Clinical Care: The Power ofPharmacogenomics. World J Pharmacol Toxicol 7: 244.

Copyright: © 2024 Rachel W. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top